Eli Lilly (LLY) GLP-1 Pill Approved: Launching Foundayo for Weight Loss
Published on Β· Source: cnbc.com
AI Summary
Summarized by AI from the source belowEli Lilly's (LLY) GLP-1 pill, Foundayo, has received FDA approval and will begin shipping via LillyDirect, available in pharmacies
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Eli Lilly and Company (LLY)
Eli Lilly is a major pharmaceutical company known for diabetes and obesity treatments and a broad drug pipeline.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier LLY news
- Lilly (LLY) Wins FDA Approval for Oral Obesity Drug Foundayo
- Eli Lilly (LLY) stock surges after FDA obesity pill approval
- Lilly (LLY) to Acquire Centessa for OX2R Sleep Disorders
- Stocks Soar on Hopes of Iran War Resolution Amid Market Optimism
- Centessa (CNTA) Downgraded After Lilly Deal Announcement
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
